SILVERARC CAPITAL MANAGEMENT, LLC: 13F holdings
CIK 18163072026Q2
| Positions | 73 |
|---|
| Reported value | $962.2m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 73 (+0 vs prior quarter) |
|---|
| Reported value | $962.2m (-1.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ASCENDIS PHARMA A/S | 206,234 | $55.0m | 5.7% |
| CELC CELCUITY INC | 500,996 | $52.4m | 5.4% |
| COGT COGENT BIOSCIENCES INC | 1,280,707 | $49.6m | 5.2% |
| UROGEN PHARMA LTD | 1,301,979 | $47.9m | 5.0% |
| IMNM IMMUNOME INC | 2,017,009 | $42.7m | 4.4% |
| DNTH DIANTHUS THERAPEUTICS INC | 390,000 | $38.0m | 4.0% |
| RYTM RHYTHM PHARMACEUTICALS INC | 311,461 | $34.6m | 3.6% |
| ORKA ORUKA THERAPEUTICS INC | 352,802 | $33.6m | 3.5% |
| GLUE MONTE ROSA THERAPEUTICS INC | 1,108,295 | $26.8m | 2.8% |
| SNDX SYNDAX PHARMACEUTICALS INC | 1,214,390 | $26.5m | 2.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1816307")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples